WGRX Q1 2026 Earnings EPS Loss of 007 Triggers Sharp Decline PAPL Q3 2025 Earnings EPS Surprises Positively Despite Revenue Uncertainty Stock Declines ATOS Q1 2026 Earnings Narrowing Loss Exceeds Expectations Amid Clinical Progress CURI Q1 2026 Earnings EPS Miss Amid Subscriber Challenges IBRX Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress Nathans Famous Inc NATH Q4 2024 Earnings EPS of 096 Despite Quiet Quarter Stock Edges Lower